Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

Gérald Simonneau, Adam Torbicki, Marius M. Hoeper, Marion Delcroix, Kristóf Karlócai, Nazzareno Galiè, Bruno Degano, Diana Bonderman, Marcin Kurzyna, Michela Efficace, Ruben Giorgino, Irene M. Lang
European Respiratory Journal 2012 40: 874-880; DOI: 10.1183/09031936.00137511
Gérald Simonneau
*AP-HP Hôpital Antoine Béclère, Dept of Pneumology, Clamart, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gerald.simonneau@abc.aphp.fr
Adam Torbicki
#Dept of Pulmonary Circulation and Thromboembolic Diseases, Postgraduate Medical School, ECZ-Otwock, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marius M. Hoeper
¶Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion Delcroix
+University Hospitals (UZ) Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristóf Karlócai
§Semmelweis University, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazzareno Galiè
fUniversity of Bologna, Institute of Cardiology, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Degano
*AP-HP Hôpital Antoine Béclère, Dept of Pneumology, Clamart, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Bonderman
**Medical University of Vienna, Dept of Internal Medicine II, Division of Cardiology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcin Kurzyna
#Dept of Pulmonary Circulation and Thromboembolic Diseases, Postgraduate Medical School, ECZ-Otwock, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michela Efficace
##Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruben Giorgino
##Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene M. Lang
**Medical University of Vienna, Dept of Internal Medicine II, Division of Cardiology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 4 874-880
DOI 
https://doi.org/10.1183/09031936.00137511
PubMed 
22362844

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received August 11, 2011
  • Accepted January 11, 2012
  • Published online September 30, 2012.

Article Versions

  • previous version (February 23, 2012 - 06:07).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©ERS 2012

Author Information

  1. Gérald Simonneau*⇓,
  2. Adam Torbicki#,
  3. Marius M. Hoeper¶,
  4. Marion Delcroix+,
  5. Kristóf Karlócai§,
  6. Nazzareno Galièf,
  7. Bruno Degano*,
  8. Diana Bonderman**,
  9. Marcin Kurzyna#,
  10. Michela Efficace##,
  11. Ruben Giorgino## and
  12. Irene M. Lang**
  1. *AP-HP Hôpital Antoine Béclère, Dept of Pneumology, Clamart, France
  2. #Dept of Pulmonary Circulation and Thromboembolic Diseases, Postgraduate Medical School, ECZ-Otwock, Warsaw, Poland
  3. ¶Hannover Medical School, Hannover, Germany
  4. +University Hospitals (UZ) Leuven, Leuven, Belgium
  5. §Semmelweis University, Budapest, Hungary
  6. fUniversity of Bologna, Institute of Cardiology, Bologna, Italy
  7. **Medical University of Vienna, Dept of Internal Medicine II, Division of Cardiology, Vienna, Austria
  8. ##Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
  1. G. Simonneau, National Reference Center for Pulmonary Hypertension South Paris University, Hôpital Antoine Béclère, 157 rue de la Porte de Trivaux, 92141 Clamart Cedex, France. E-mail: gerald.simonneau{at}abc.aphp.fr
View Full Text

Article usage

Article usage: February 2012 to January 2023

AbstractFullPdf
Feb 201292015
Mar 20121700106
Apr 201291064
May 201253031
Jun 201265029
Jul 201265041
Aug 201292033
Sep 2012197245
Oct 2012228372214
Nov 20129841951
Dec 20124051336
Jan 20134261728
Feb 20131781334
Mar 20131832229
Apr 20131651523
May 20131272122
Jun 2013741620
Jul 201372820
Aug 2013511316
Sep 2013571015
Oct 2013801634
Nov 201353722
Dec 2013672626
Jan 2014722043
Feb 2014561230
Mar 2014561737
Apr 2014506664
May 2014606064
Jun 2014478895
Jul 2014577060
Aug 2014324540
Sep 2014526167
Oct 2014606853
Nov 2014417258
Dec 2014405950
Jan 2015315655
Feb 2015477451
Mar 2015337254
Apr 20154510369
May 2015487564
Jun 20155010967
Jul 201514320379
Aug 201514516851
Sep 2015129160133
Oct 20159318397
Nov 201510317698
Dec 2015130216158
Jan 2016150434357
Feb 2016147262324
Mar 2016102250193
Apr 201673193148
May 201672147139
Jun 201662178143
Jul 20162910695
Aug 201630131112
Sep 201639172161
Oct 201643185100
Nov 201638248105
Dec 20163115777
Jan 20172617364
Feb 20172516677
Mar 20172316258
Apr 20173610562
May 2017329154
Jun 20172511490
Jul 20171415587
Aug 20171510957
Sep 20172612569
Oct 2017379250
Nov 2017308173
Dec 2017199183
Jan 20181611145
Feb 2018148048
Mar 20182111065
Apr 20181915986
May 2018148153
Jun 2018910250
Jul 2018911161
Aug 20181316567
Sep 20181616569
Oct 20181515862
Nov 20181116862
Dec 2018714768
Jan 20191110368
Feb 20191410552
Mar 20191810464
Apr 20192311957
May 20191714558
Jun 20191013942
Jul 20191014542
Aug 20192014243
Sep 2019515333
Oct 20191317959
Nov 2019912338
Dec 20191010337
Jan 20201012167
Feb 2020137243
Mar 20201510444
Apr 20201311454
May 20201512363
Jun 20202016166
Jul 2020815844
Aug 20201011149
Sep 20201517449
Oct 202013175116
Nov 20201518884
Dec 20201519169
Jan 2021329152
Feb 20211529687
Mar 20212331388
Apr 20211226663
May 20211325159
Jun 20212119948
Jul 20212023351
Aug 202112027357
Sep 20211634661
Oct 2021738587
Nov 20211733469
Dec 20213134162
Jan 20221729754
Feb 20221028069
Mar 20221226779
Apr 2022923051
May 20221119149
Jun 20221520171
Jul 2022916560
Aug 20222632178
Sep 20221327268
Oct 20221536464
Nov 20221839245
Dec 20221022849
Jan 2023720525

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 40 Issue 4 Table of Contents
European Respiratory Journal: 40 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Gérald Simonneau, Adam Torbicki, Marius M. Hoeper, Marion Delcroix, Kristóf Karlócai, Nazzareno Galiè, Bruno Degano, Diana Bonderman, Marcin Kurzyna, Michela Efficace, Ruben Giorgino, Irene M. Lang
European Respiratory Journal Oct 2012, 40 (4) 874-880; DOI: 10.1183/09031936.00137511

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Gérald Simonneau, Adam Torbicki, Marius M. Hoeper, Marion Delcroix, Kristóf Karlócai, Nazzareno Galiè, Bruno Degano, Diana Bonderman, Marcin Kurzyna, Michela Efficace, Ruben Giorgino, Irene M. Lang
European Respiratory Journal Oct 2012, 40 (4) 874-880; DOI: 10.1183/09031936.00137511
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Prediction of new-onset asthma and nasal allergy
  • Mortality and causes of death in HIV/tuberculosis patients
Show more Original Article

Pulmonary Vascular Disease

  • COVID-19 and case fatality in pulmonary embolism
  • PULSAR: sotatercept for the treatment of PAH
  • Emerging phenotype of PAH patients carrying SOX17 variants
Show more Pulmonary Vascular Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society